Free access supported by contributions and sponsoring — share your knowledge or support us financially
Search / Compare / Validate Lab equipment & Methods

N methylimidazole

Manufactured by Merck Group
Sourced in United States, Germany, France, Poland
About the product

N-methylimidazole is a heterocyclic organic compound used in various laboratory applications. It is a colorless to pale yellow liquid with a characteristic odor. N-methylimidazole serves as a building block and intermediate in the synthesis of other chemical compounds. Its core function is to provide a reactive imidazole moiety for further chemical transformations.

Automatically generated - may contain errors

Market Availability & Pricing

Is this product still available?

Get pricing insights and sourcing options

The spelling variants listed below correspond to different ways the product may be referred to in scientific literature.
These variants have been automatically detected by our extraction engine, which groups similar formulations based on semantic similarity.

Product FAQ

44 protocols using «n methylimidazole»

1

Synthesis of Hydroxyl-Functionalized Ionic Liquids

2024
For the synthesis of hydroxyl-functionalized ionic liquids (ILs), N-methylimidazole (Sigma-Aldrich, Burlington, MA, USA), 3-chloro-1,2-propanediol (Sigma-Aldrich), ethyl acetate (Neon Química, São Paulo, Brazil), lithium bis(trifluoromethanesulfonyl)imide (LiNT2F, Sigma-Aldrich, USA), lithium tetrafluoroborate (LiBF4, Sigma-Aldrich, USA), and sodium hexafluorophosphate (NaPF6, Sigma-Aldrich, USA) were used. To obtain the PILs, polycarbonate diol (PCD, Mn = 2000 g/mol, Bayer, Berlin, Germany), hexamethylene diisocyanate (HDI, 99%, Merck, Darmstadt, Germany), dibutyltin dilaurate (DBTDL, Miracema Nuodex, Campinas, Brazil), methyl ethylketone (MEK, 99%, Mallinckrodt, Hazelwood, MO, USA) and the obtained ILs glyceryl-N-methylimidazolium chloride [GLYMIM][Cl], and derivatives ([GLYMIM][Cl], [GLYMIM][NT2F], ([GLYMIM][BF4] and ([GLYMIM][PF6]) were used.
+ Open protocol
+ Expand Check if the same lab product or an alternative is used in the 5 most similar protocols
2

Structural Analysis of Amino Acid-Functionalized Chlorosilanes

2023
The starting material (tBuNH)2SiMe2 was prepared according to a published method [42 (link)]. The amino acids α-aminoisobutyric acid (Roth, Karlsruhe, Germany, ≥97%), D-phenylglycine, and L-valine (Merck, Darmstadt, Germany, ≥99%) were commercially available and were used without further purification. (Note: For the chiral amino acids, phenylglycine, and valine, the choice of the respective enantiomer was made by the availability of the starting materials from previous studies.) N-Methylimidazole (Sigma-Aldrich, Steinheim, Germany, ≥99%), chloroform, stabilized with amylenes (Honeywell, Seelze, Germany, ≥99.5%) and CDCl3 (Deutero, Kastellaun, Germany, 99.8%) were stored over activated molecular sieves (3 Å) for at least 7 days and used without further purification. All reactions were carried out under an atmosphere of dry argon utilizing standard Schlenk techniques. Solution NMR spectra (1H, 13C, 29Si) (cf. Figures S1–S13 in the supporting information) were recorded on Bruker Avance III 500 MHz and Bruker Nanobay 400 MHz spectrometers. 1H, 13C and 29Si chemical shifts are reported relative to Me4Si (0 ppm) as internal reference. (Note: The referencing of 1H and 13C chemical shifts against solvent signals is not useful in these systems which contain large amounts of strong hydrogen bond acceptors, e.g., NMI. Such components may influence the 1H and 13C chemical shift of chloroform noticeably. For instance, in a 1H NMR spectrum of a solution of NMI in TMS-containing CDCl3, which was recorded for a purity check of the NMI used, the residual CHCl3 signal emerged at 7.37 ppm rather than at 7.26 ppm in neat CDCl3.) For single-crystal X-ray diffraction analysis of (Phg)SiMe2-NMI · 2CHCl3 a crystal was selected under an inert oil on an ice-cooled Petri dish, mounted on a glass capillary and instantly moved to the cold nitrogen stream of the diffractometer. In the case of (Aib)SiMe2-NMI · CHCl3, the compound was allowed to melt at room temperature, whereupon a small amount of the melt was transferred into a glass capillary, which was then sealed, mounted on the goniometer, and slowly cooled to allow for the re-crystallization of the compound inside the capillary on the diffractometer. (The crystallization procedure was similar to our approach of crystallizing chlorosilanes for X-ray diffraction analyses [43 (link)].) Diffraction data were collected on a Stoe IPDS-2 diffractometer (STOE, Darmstadt, Germany) using Mo Kα-radiation. Data integration and absorption correction were performed with the STOE software XArea (version 1.75) and XShape (version 2.17), respectively. The structures were solved using SHELXT [44 (link)] and refined with the full-matrix least-squares methods of F2 against all reflections with SHELXL-2018/3 [45 ,46 (link)]. All non-hydrogen atoms were anisotropically refined, and hydrogen atoms were isotropically refined in an idealized position (riding model). For details of data collection and refinement see Appendix A, Table A1. Graphics of molecular structures were generated with ORTEP-3 [47 (link),48 (link)] and POV-Ray 3.7 [49 ].
The geometry optimizations were carried out with ORCA 5.0.3 [50 (link)] using the restricted PBE0 functional with relativistically recontracted Karlsruhe basis sets ZORA-def2-TZVPP [51 (link),52 (link)] for all atoms, the scalar relativistic ZORA Hamiltonian [53 (link),54 (link)], atom-pairwise dispersion correction with the Becke–Johnson damping scheme (D3BJ) [55 (link),56 (link)], and COSMO solvation (CHCl3, ε = 4.8, rsolv = 3.17). Very-TightSCF and slowconv options were applied and the DEFGRID3 was used with a radial integration accuracy of 10 for Si for all calculations. Calculations were started from the molecular structures obtained by single-crystal X-ray diffraction analysis. Numerical frequency calculations were performed to prove convergence at the local minimum after geometry optimization and to obtain the Gibbs free energy (293.15 K). NMR calculations were carried out with ORCA 5.0.3 at the same level of theory as mentioned above. Graphics were generated using ChemCraft [57 ].
+ Open protocol
+ Expand Check if the same lab product or an alternative is used in the 5 most similar protocols
3

Synthesis and Characterization of [C4MIM][OMs]

2023
1-butyl-3-methylimidazolium methane sulfonate was prepared by mixing 0.60 g of n-methylimidazole (Sigma Aldrich, St. Louis, USA) and 1.8 g 1-butyl-methanesulfonate (Sigma Aldrich, St Louis, USA) simultaneously inside a 250 ml tumbler and stirred for 30 min. The stirred mixture was put in a microwave and radiated for 8 min using 1-butyl-3-methylimidazolium tetrafluoroborate [bmim][BF4] as a catalyst at temperature of 110–115 °C [43 ]. The product was collected, washed four times and dehumidified using ethyl acetate. [C4MIM][OMs] was obtained and the yield was 96.10% and melting point in the range of 71–73 °C. All chemicals employed were of analytical grade and were used without further purification.
In order to have an insight on the structural characteristics of [C4MIM][OMs] molecules before and after corrosion, infrared spectroscopy (FT-IR) was performed using PerkinElmer 100 F T-IR spectrophotometer meter for the pure and after corrosion inhibition (5hr immersion). The FTIR analysis was performed within the wavelength of 400–4000 cm−2. Furthermore, SEM/AFM analysis of corroded and inhibited metal surfaces after 5hr was performed using scanning electron microscope (model-JEOL-JSM-6390) Czech Republic. Also, atomic mass spectroscopy was performed using Pipcoplus 2500 to successfully inspect the surface roughness of the corroded and inhibited metal surface [44 ].
+ Open protocol
+ Expand Check if the same lab product or an alternative is used in the 5 most similar protocols
4

Synthesis of Functional Polymer Electrolytes

2023
Poly(ethylene glycol)methyl
ether methacrylate (PEGM, Mn = 500 g/mol,
Aldrich), 1-butyl-3-methylimidazolium bromide (99%, Iolitec), magnesium
sulfate (MgSO4, anhydrous, 99.5%, Aldrich), 4-methoxyphenol
(99%, Aldrich), 2-phenylethyl methacrylate (PhEtM, 98%, Jinan Yudong
Technology Co., Ltd.), 2-[2-(chloroethoxy)-ethoxy]ethanol (>98%,
TCI
Europe), lithium bis(trifluoromethylsulfonyl)imide (LiTFSI, >99%,
Solvionic), N-methylimidazole (>99%, redistilled,
Aldrich), 3-sulfopropyl methacrylate potassium salt (98%, Aldrich),
4-cyano-4-(phenylcarbonothioylthio)pentanoic acid (CPAD, chain-transfer
agent (CTA), >97%, Aldrich), octadecyltrichlorosilane (OTS, ≥90%,
Aldrich), dichloromethane (DCM, 99.8%, Aldrich), dimethylformamide
(DMF, anhydrous, 99.5%, Acros), diethyl ether (99%, Aldrich), methanol
(99.8%, Aldrich), golden leafs/foil (22 carat, Carl ROTH), chromium-coated
tungsten rods (Cr, Angstrom Engineering), and gold (Au, 99.99%, Angstrom
Engineering) were used as received. Single-walled carbon nanotubes
(SWCNTs, Raymor Industries, diameter ∼ 1.5 nm, length 0.3–4.0
μm) were purified using a poly(9,9′-didodecylfluorene-co-N-(2′-decyltetradecane)-carbazole)
polymer (PCPF) in toluene following previously reported procedures.30 (link),31 (link) Methacryloyl chloride (>97%, Acros) and thionyl chloride (99.7%
Acros) were distilled over linseed oil. N-Methylpyrrolidine
(97%, Aldrich) was distilled under vacuum prior to use. 2,2′-Azobisisobutyronitrile
(AIBN, initiator, 98%, Acros) was recrystallized from methanol. 4-methoxyphenol
(99%, Acros) was sublimed in vacuum prior to use. Lithium 1-[3-(methacryloyloxy)propylsulfonyl]-1-(trifluoromethanesulfonyl)imide
was synthesized in accordance with the procedures published previously.32 (link),33 (link)
+ Open protocol
+ Expand Check if the same lab product or an alternative is used in the 5 most similar protocols
5

Mild Steel Corrosion Inhibition Study

2023
Ethanol (CH3CH2OH) 96.8%, Acetone (CH3COCH3), 96.4%, n-methylimidazole, 1-butyl methyl sulfonate were purchased from Sigma-Aldrich. Mild steel composition is as follows: Mn (0.14%), P (0.23%), Si (0.04%), S (0.11%), C (0.25%), Cr (0.03%), Ni (0.08%), and Fe (99.12%). Prior to experiment, the specimen was cut into 4 cm × 3 cm x 0.1 cm, polished with emery papers (180, 200 and 1200 grits size). The impurities on the specimen was removed with acetone, rinsed with distilled water and dried in warm air. This is in line with the conventional method already reported [42 ].
+ Open protocol
+ Expand Check if the same lab product or an alternative is used in the 5 most similar protocols

Top 5 protocols citing «n methylimidazole»

1

Synthesis of Hybrid Lithium-ion Conductive Membranes

3-Glycidoxypropyl-trimethoxysilane (GPTMS) (98%), EGDE (99%), and trimethyltriethoxysilane (TMES) (95%) were used as received and purchased from ABCR Company. n-Methylimidazole (n-MI,99%) and LiTFSI (99.95%) from Sigma-Aldrich was used as an initiator for the epoxy group copolymerization and lithium salt, respectively. LiFFSI was dried at 120 °C in a glovebox. Absolute ethanol (99.5%) from Panreac was distilled (Karl–Fischer titration 55 ppm H2O) and was used as solvent.
The synthesis procedure consists in the initial formation of the organic network and, then, the sol-gel reactions (hydrolysis and condensation) forming inorganic networks are promoted, according to the procedure that was followed for the development of the termed “star-branched silica based architectures” [25 (link),28 (link),29 (link)]. The preparation of the materials consists of three stages: (i) formation of the organic network; (ii) formation of inorganic environments (sol-gel reactions); (iii) blocking of hydrolyzed groups, uncondensed Si-OH groups, with trimethyltriethoxysilane (TMES), in order to avoid the effect of proton conduction on the conductivity measurement; and, (iv) Once the hybrid structure is formed, the lithium salt (LiTFSI) is added to obtain the desired Li-ion conductive material. The flux diagram describing synthesis strategy for the preparation of GTT: GPTMS/TMES/TPTE compositions are shown in the Figure 1.
Five compositions of the GTT system (Table 1) have been synthesized, varying the ratio between the precursors (GPTMS and TPTE). [Li]/[O] ratio was fixed to 0.10 (based on a previous work [28 (link)]), and also non-doped Li composition was studied for comparison.
The materials have been processed as coatings while using the immersion-extraction process and as self-supported membranes. The coatings were deposited on soda-lime glass slides (2.5 × 7 cm2) and they were processed at room temperature inside a glove box (Ar) that was equipped with a dip-coater. Extraction speeds between 4.5 and 20 cm min−1 were used. The coatings were dried at room temperature for 30 minutes and, subsequently, they were thermally treated at 100 °C for 12 h in an oven (HOBERSAL Model JB-15) (with a constant heating ramp of 1 °C/min.) inside the glove box to complete the drying and sintering of the material. The preparation of the self-supported membranes was based on the casting of the sol in Teflon molds inside the glove box, allowing for the solvent to evaporate for several days at room temperature and, subsequently, treated at 60 °C for 24 h. The membranes were demoulded and treated thermally at 100 °C in order to accelerates condensation of inorganic precursor and consolidate the hybrid structure while using a constant heating ramp at 1 °C/min. for 12 h in an inert atmosphere (Ar).
+ Open protocol
+ Expand Check if the same lab product or an alternative is used in the 5 most similar protocols
2

Synthesis of the Antiviral Compound NUC-3073

The compound NUC-3073 (Fig. 1) (1) has been synthesized using phosphorochloridate chemistry as previously reported by McGuigan et al. [30] [31] [32] . Arylphosphorodichlorophosphate (2) has been prepared by coupling commercially available 1-naphthol (Sigma-Aldrich, Dorset, UK) (3) with phosphorus oxychloride (Sigma-Aldrich) (4) in the presence of Et 3 N (Sigma-Aldrich) (Scheme 1) and this was allowed to react with L-alanine benzyl ester tosylate (NovaBiochem (now Merck Chemicals Ltd, Darmstadt, Germany)) (5) in the presence of Et 3 N to generate the phosphorochloridate derivative (6) (Scheme 2).
The nucleoside 5-FdUrd (Fig. 1) (Carbosynth Ltd, Berkshire, UK) (7) was converted to the 5 0 -ProTide derivative by coupling with the phosphorochloridate derivative (6) in THF (Sigma-Aldrich) in the presence of N-methyl imidazole (NMI) (Sigma-Aldrich) to give the target compound NUC-3073 (1) (Scheme 3). The product was obtained as a mixture of two diastereoisomers as confirmed by the presence of two peaks in the 31 P and 19 F NMR spectra, and two closely spaced peaks detectable by HPLC.
Alternatively, the compound 1 was prepared using tBuMgCl (Sigma-Aldrich) (1 M solution in THF). Due to the lack of selectivity towards the primary hydroxyl group, formation of 3 0 -O-phosphorylated derivative 8 was also observed (Scheme 4).
+ Open protocol
+ Expand Check if the same lab product or an alternative is used in the 5 most similar protocols
3

Comprehensive Reagent Inventory for Analytical Assays

Pepsin (2000 FIP-U/g), glucose, inositol and N-methylimidazole were obtained from Merck (Darmstadt, Germany). Amyloglucosidase (14 IU/mg) was from, Roche, Manheim, Germany. Pancreatin, αamylase (17.5 IU/mg), 2,2′-Azino-bis(3-ethylbenzo-thiazoline-6sulfonic acid) (ABTS), 6-hydroxy-2,5,7,8-tetramethylchroman-2carboxylic acid (Trolox), catechin, gallic acid, galacturonic acid, galactose and mannose were obtained from Sigma-Aldrich Química, S.A. (Madrid, Spain). 2,4,6-Tris(2-pyridyl)-s-triazine (TPTZ) was from Fluka Chemicals (Madrid, Spain). Dinitrosalicylic acid, 3,6′-dihydroxyspiro-[isobenzofuran-1-[3H],90[9H]-xanthen]-3-one (fluorescein) and iron III-chlorure-6-hydrate were from Panreac, Castellar del Vallés (Barcelona, Spain). All reagents used were of analytical grade.
+ Open protocol
+ Expand Check if the same lab product or an alternative is used in the 5 most similar protocols
4

High-Throughput Screening of Protein Inhibitors

All reagents and solvents from commercial suppliers were used without further purification. Alkaline phosphatase-conjugated goat anti-mouse IgG, BICINE, BIS-TRIS, bovine kidney alkaline phosphatase, 5-bromo-4-chloro-3-indolyl phosphate/nitro blue tetrazolium tablets (BCIP/NBT), p-nitrophenyl phosphate substrate tablets (p-NPP), and suramin were from Sigma (St. Louis, USA). Levamisole, N-methylimidazole and tetramisole were from Aldrich (Milwaukee, WI, USA), (–)-p-bromoLevamisole oxalate was from Sigma-Aldrich (Schnelldorf, Germany), and 4-(2,3-dihydroimidazo-[2,1-b]thiazol-6-yl)aniline was from Maybridge (Trevillett, UK). Human serum albumin (HSA) and TTN buffer (0.05 M Tris, pH 7.5, 0.3 M NaCl, 1% v/v Tween 20) were from Statens Serum Institut (Copenhagen, Denmark). Ethanol (96%) was from Danisco (Aalborg, Denmark). Acetic acid, acetone, DMSO, Na2HPO4, NaH2PO4, Tween 20, NaCl, HPLC-grade acetonitrile, and formic acid were from Merck (Darmstadt, Germany). Mouse anti-human CD31 was from Monosan (Uden, Netherlands). Goat anti-recombinant human vascular endtothelial growth factor (Anti-VEGF), recombinant basic fibroblast growth factor (bFGF) and recombinant human vascular endothelial growth factor (VEGF) were from R&D Systems (Minneapolis, MN, USA). Human umbilical vein endothelial cells (HUVEC), normal human dermal fibroblast (NHDF), the HUVEC media-kit EGM-2 Bulletkit, and the fibroblast media-kit FGM-2 Bulletkit were from Clonetics, BioWhittaker (Walkersville, MD, USA). Polystyrene 96-microwell plates were from Thermo Fischer Scientific (Roskilde, Denmark). TrifluoroAcetic acid (TFA) was from Rathburn (Walkerburn, Scotland, UK). Porous column material was from Applied Biosystems (Foster City, California, USA). PBS was made from 8 mM Na2HPO4, 2 mM NaH2PO4, 0.15 M NaCl, pH 7.3. 1H and 13C NMR spectra were recorded on a Bruker AMX 400 instrument and are reported in δ units (ppm). The solvent peak (CDCl3 or CD3OD) was used as internal reference. Values of coupling constants J are given in Hz and the signal multiplicities are shown in parentheses (singlet (s), doublet (d), triplet (t), quartet (q), heptet (h), multiplet (m)). For an example (compound 12) of a full assignment of the signals, see Table S1. Optical rotations were measured on a 241 polarimeter (Perkin Elmer, Waltham, Massachusets, USA). Vacuum liquid chromatography (VLC) was performed with silicagel 60 H (particle size <45 μm). Preparative reversed phase HPLC separations were carried out on a Phenomenex Luna 250×21.2 mm, C18 column (5 μm) using an Agilent system consisting of two preparative scale pumps, an autosampler, and a multiple-wavelength UV detector. A gradient elution systems consisting of eluent A (H2O–MeCN–TFA 95∶5∶0.1) and eluent B (H2O–MeCN–TFA 5∶95∶0.1), rising linearly from 0% to 30% of B during 25 min was used. The eluent flow rate was maintained at 20 mL/min and injection volumes were 900 μL. HRMS was performed by Ultra High Performance Liquid chromatography-high resolution mass spectrometry (UHPLC-HRMS) on a maXis G3 quadrupole time-of-flight mass spectrometer (Bruker Daltonics, Bremen, Germany) equipped with an electrospray (ESI) source. The MS was connected to an Ultimate 3000 UHPLC system (Dionex, Sunnyvale, CA). Separation of 1 µL samples were performed at 40°C on a 100 mm ×2.1 mm, 2.6 µm Kinetex C18 column (Phenomenex, Torrance, CA) using a linear water-acetonitrile gradient (both buffered with 20 mM formic acid) at a flow of 0.4 mL min−1 starting from 10% acetonitrile and increased to 100% over 10 minutes. MS was performed in ESI+ with a data acquisition range of 10 scans per sec at m/z 100–1000. The MS was calibrated using sodium formate automatically infused prior to each analytical run, providing a mass accuracy of less than 0.5 ppm in MS mode.
+ Open protocol
+ Expand Check if the same lab product or an alternative is used in the 5 most similar protocols
5

Synthesis of Hydroxyl Functional Ionic Liquid

Example 2

Synthesis of Hydroxyl Functional Methylimidazolium Chloride Ionic Liquid:

Into a 500-milliliter, 4-necked kettle equipped with a stirrer, a condenser, a nitrogen inlet, and a thermocouple in a heating mantle, was charged of 3-chloro-1-propanol (48.06 g, 0.5084 mol, commercially available from Aldrich), N-methylimidazole (39.75 g, 0.4842 mol, commercially available from Aldrich), and toluene (79.50 mL). Agitation by an air motor and a nitrogen flow of 0.2 scft/min were started. The reaction mixture was heated to reflux for 5 hours. The reaction mixture was allowed to cool to 70° C. and the reaction progress was monitored using a TLC plate. Dibutyltin dilaurate (0.029 g, commercially available from Air Product & Chemicals) was then added into reaction mixture and followed by the addition of isocyanatopropyl trimethoxy silane (99.25 g, 0.384 mol, commercially available from Momentive) into reaction mixture drop wise over 30 minutes. Butyl acetate (10 mL) was then used to rinse the additional funnel. After addition, the reaction mixture was held until the isocyanate peak at 2259 cm−1 was no longer detected by a Thermo Scientific Nicolet iS5 FT-IR Spectrometer. The reaction mixture was then allowed to cool to 40° C. and the agitation was stopped. After 10 minutes, the reaction mixture separated into two phases. The solvent-containing phase was removed by decanting. The remaining solvent was removed by vacuum distillation. An orange oil was obtained.

+ Open protocol
+ Expand Check if the same lab product or an alternative is used in the 5 most similar protocols

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!

🧪 Need help with an experiment or choosing lab equipment?
I search the PubCompare platform for you—tapping into 40+ million protocols to bring you relevant answers from scientific literature and vendor data.
1. Find protocols
2. Find best products for an experiment
3. Validate product use from papers
4. Check Product Compatibility
5. Ask a technical question
Want to copy this response? Upgrade to Premium to unlock copy/paste and export options.